Welcome to our dedicated page for Celanese Del news (Ticker: CE), a resource for investors and traders seeking the latest updates and insights on Celanese Del stock.
Celanese Corporation (NYSE: CE) is a global specialty materials and chemical company that regularly issues news and updates related to its operations, financial performance and strategic decisions. The company describes itself as a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Its news flow reflects both its role in the basic organic chemical manufacturing industry and its position as a Fortune 500 company.
Investors following Celanese news can expect frequent announcements on earnings and investor communications. The company issues press releases and hosts conference calls and webcasts to discuss quarterly financial results, as seen in its announcement of a fourth quarter earnings conference call and related 8-K filings. Celanese also participates in investor events, including fireside chats with financial institutions, where its President and Chief Executive Officer presents to investors and analysts.
Celanese news also covers capital structure and financing activities. Recent releases describe registered offerings of senior notes by its subsidiary Celanese US Holdings LLC, the pricing and upsizing of those offerings, and cash tender offers for existing senior notes due in 2027 and 2028. Related updates explain how proceeds are used to repay borrowings under a term loan credit agreement, fund tender offers and support general corporate purposes.
Operational and portfolio developments appear in the company’s news as well. Celanese has announced the intended closure of an acetate tow production facility in Lanaken, Belgium, to streamline production costs, and the signing of a purchase and sale agreement to divest its Micromax® portfolio of products. Other news highlights sustainability-related milestones, such as achieving ISCC Carbon Footprint Certification for certain POM ECO-C grades at production sites in Frankfurt, Germany, and Bishop, Texas, reflecting the company’s stated focus on responsible material management and sustainable products.
By monitoring Celanese news, readers can track updates on governance changes, such as Board member resignations, sustainability initiatives, financing transactions and scheduled earnings events that shape the company’s strategic direction.
Celanese Corporation (NYSE: CE) announced a price increase for several products effective December 1, 2022, or as contracts allow. Notable increases include a 15% hike for UHMW-PE across APAC, AMER, and EMEA, and specific increases per kg for different materials such as 0.50 for LCP and 1.50 for AEM. The company's strong positioning in specialty materials will support these changes, which aim to mitigate rising costs. This strategic decision is consistent with Celanese's efforts to enhance profitability amidst market challenges.
Celanese Corporation (NYSE: CE) reported third quarter 2022 diluted EPS of $1.76 and adjusted EPS of $3.94, with net sales of $2.3 billion, reflecting a 7% decline from the prior quarter. The decrease resulted from a price drop of 3% and a volume reduction of 2%. Operating profit stood at $308 million, impacted by rising costs and a decline in demand, particularly in Europe and Asia. The acquisition of Mobility & Materials completed on November 1, 2022, aims to enhance growth. Fourth quarter adjusted EPS guidance is set between $1.50 and $2.00, factoring in the acquisition's impact.
Celanese Corporation (NYSE: CE) has successfully acquired the majority of the Mobility & Materials (M&M) business from DuPont. This acquisition enables Celanese to enhance its position as a global leader in specialty materials, incorporating renowned brands and extensive product portfolios into its operations. The transaction, initially announced in February 2022, includes a range of engineered thermoplastics and elastomers along with global production capabilities. Future commentary on the acquisition will be provided during the upcoming third-quarter earnings call.
Celanese Corporation (NYSE: CE) has announced the lifting of the force majeure declared on May 11, 2022, for several Acetyl Chain products in the Western Hemisphere, including acetic acid and vinyl acetate monomer. However, the company is unable to lift the force majeure for its acetate tow products due to ongoing supply chain issues. Celanese continues to assess its supply and logistics challenges and will notify when normal supply resumes.
Celanese Corporation (NYSE: CE) has declared a quarterly cash dividend of $0.70 per share, an increase from the previous $0.68 per share, effective November 14, 2022, to shareholders on record as of October 31, 2022. This 3% raise reflects a commitment to returning value to shareholders, representing an additional cash outlay of less than $10 million based on current shares. Celanese emphasizes a decade-long history of annual dividend growth, aligning this increase with their deleveraging plan following the acquisition of Mobility & Materials.
Summary not available.
Celanese Corporation (NYSE: CE) has announced a significant investment in expanding its capabilities to meet the rising global demand for pharmaceutical-grade polymers. A new 1,000-square-foot cleanroom facility in Edmonton, Alberta, will be dedicated to cryogenic micronization of VitalDose® EVA material. This process aims to enhance drug delivery solutions for various medical conditions, including cancer and retinal disorders. The facility is expected to begin operations by early 2023, further solidifying Celanese's position in the pharmaceutical market.
Celanese Corporation (NYSE: CE) is set to host its third quarter 2022 earnings call on
Celanese Corporation (NYSE: CE) has received a grant from the Bill & Melinda Gates Foundation to develop a refillable contraceptive implant. This project aims to create a functional prototype within 18 months, focusing on enhancing access to contraceptive options for women in low- and middle-income countries. The development will leverage Celanese's VitalDose® drug delivery technology, which has a strong history in women's health. This initiative aligns with Celanese's mission to expand healthcare access globally.
Celanese Corporation (NYSE: CE) reported second quarter 2022 GAAP diluted EPS of $4.03 and adjusted EPS of $4.99, with net sales of $2.5 billion, reflecting a 2% decrease from the prior quarter but a 13% increase year-over-year. The company successfully offset supply interruptions and inflation, achieving an operating profit of $483 million. Record sales in Engineered Materials reached $948 million. The firm secured $10.5 billion in financing for the DuPont M&M acquisition. However, they anticipate softening demand and expect adjusted EPS of $4.00 to $4.50 for Q3.
FAQ
What is the current stock price of Celanese Del (CE)?
What is the market cap of Celanese Del (CE)?
